Opportunity
SAM #SSNIHS1522413
Sources Sought: Alcor ISED Elite ESR Analyzer Instrument Placement for Indian Health Service
Buyer
Navajo Area Indian Health Service
Posted
April 17, 2026
Respond By
April 27, 2026
Identifier
SSNIHS1522413
NAICS
532283, 325413
The Indian Health Service, Chinle Service Unit (under the Navajo Area Indian Health Service, Department of Health and Human Services) is seeking information from qualified Indian-owned economic enterprises for instrument placement of an Alcor ISED Elite ESR analyzer. - Government Buyer: - Indian Health Service, Chinle Service Unit - Navajo Area Indian Health Service - Department of Health and Human Services - OEM Highlight: - Alcor Scientific is the specified OEM for the ISED Elite ESR analyzer - Products/Services Requested: - Instrument placement (cost-per-test) of one Alcor ISED Elite ESR analyzer (part number 112-00222P) - Supplies for the analyzer to be purchased as needed - Unique/Notable Requirements: - Priority for Indian-owned economic enterprises under the Buy Indian Act - Set-asides for small businesses under the Small Business Act - Respondents must be registered in SAM.gov at time of offer and award - Required submission of company profile, capability statement, and IHS IEE Representation Form for Indian-owned businesses - NAICS code: 325413 (In-Vitro Diagnostic Substance Manufacturing) - Place of performance: Chinle Service Unit, Chinle, AZ
Description
Sources-Sought Notice
The Indian Health Service, Chinle Service Unit is issuing this sources-sought notice (SSN) to identify capable Indian-owned, economic enterprises – large (IEE) or small (ISBEE) – for instrument placement (cost-per-test) for 1 Alcor ISED Elite ESR analyzer (112-00222P) and supplies will be purchased on as needed basis.
Other capable firms are also invited to respond to this SSN. The Contracting Officer will consider responses for Buy Indian Act (25 U.S.C. 47) opportunities first, then for set aside programs under the Small Business Act (41 U.S.C. 3104).
The applicable North American Industry Classification System (NAICS) code assigned to this requirement is 325413 - In-Vitro Diagnostic Substance Manufacturing with a small business size standard of 1250 employees.
THIS IS NOT A SOLICITATION. Information collected from this notice is purely for market research only and will be used to determine the contracting office’s acquisition strategy including competition, set asides, and locating Indian-owned economic enterprises. Submission of any information in response to this market survey is purely voluntary. The government assumes no financial responsibility for any costs incurred in response to this request for information.
In accordance with FAR 4.203-1(b), offerors and quoters must be registered in System for Award Management at SAM.gov, at the time an offer or quotation is submitted and at time of award.
Submission Instructions: Interested parties who consider themselves qualified to perform the above-listed services are invited to submit a response to this notice by April 24, 2026, by 5:00pm (MST) to Nora Nutlouis, Purchasing Agent, (928) 725-9806 at nora.nutlouis@ihs.gov with the subject line “SSN - IHS1522413. Your submission must include the following information, at a minimum:
Company Profile that includes: UEI, Name and Address, Primary POC information, business size and type of ownership, socio-economic status/participation such as 8(a), WOSB/EDWOSB, SDVOSB and HUBZone, identification of Native American ownership, SAM.gov representations and certifications, and other related documentation. A brief statement of the company’s capability that relates to the described government requirement. Additional demonstration of capability may include current and past performance history for the same or similar requirement, established contracts such as GSA or VA Schedule, etc. Indian-owned Small Business Economic Enterprises (ISBEEs) and Indian-owned Economic Enterprises (IEEs) must also submit a completed IHS IEE Representation Form (attached) in accordance with HHSAR 326.606-1(b).
Telephone inquiries will not be accepted or acknowledged, and no feedback or evaluations will be provided to companies regarding their submissions.